Raymond Li

Dr. Raymond Li serves as an Honorary Senior Lecturer at the Sydney Pharmacy School within the Faculty of Medicine and Health at the University of Sydney. A registered pharmacist by profession, he currently works as a senior medical advisor in the pharmaceutical industry while maintaining his academic affiliation. His expertise bridges clinical pharmacy practice and academic research with a focus on medication safety systems and digital health innovations.

His educational qualifications include:

• Bachelor of Pharmacy (2009)
• PhD from the University of Sydney (2023)

Dr. Li's research program centers on leveraging automation and digital technologies to enhance medication safety and promote quality use of medicines. His work addresses critical gaps in health services and patient safety, particularly in adverse drug reaction reporting systems and medication management processes. He employs mixed-methods approaches to investigate healthcare professional behaviors and develops evidence-based interventions for pharmacovigilance improvement. His research directly impacts pharmaceutical industry practices and healthcare policy development.

Analysis of his publication record reveals two dominant research streams: pharmacovigilance/digital health interventions (60% of recent work) and medical education/clinical training systems (40%). The pharmacovigilance stream shows consistent focus on adverse drug reaction reporting barriers, intervention effectiveness, and digital tool development, while the education stream examines competency frameworks, clinical placement design, and assessment methodologies across health professions.

His scientific recognition includes:

• Fellow of the Australasian College of Pharmacy (2022)

Dr. Li has secured competitive research funding including a 2020 Implementation Science Grant Pilot for developing an electronic adverse drug reaction reporting tool at Blacktown Hospital. While his industry role limits direct student supervision, he actively collaborates with academic teams on medication safety research projects and contributes to curriculum development in pharmacy education. His grant portfolio demonstrates strong industry-academic partnerships focused on practical healthcare system improvements.

No dedicated research laboratories or institutional teams are currently associated with his academic profile, reflecting his primary industry-based position with honorary academic affiliation.